Last reviewed · How we verify

NCT03317041: UPV/EHU

Capacitive-resistive Electric Transfer Therapy for Recovery From Running Fatigue

Completed NA Last updated 23 October 2017
What this trial tests

NA trial testing Capacitive-resistive electric transfer (Tecar) therapy in Running in 14 participants. Completed in 28 September 2016.

Timeline
1 March 2016
Primary endpoint
31 July 2016
28 September 2016

Quick facts

Lead sponsorUniversity of the Basque Country (UPV/EHU)
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeother
Enrollment14
Start date1 March 2016
Primary completion31 July 2016
Estimated completion28 September 2016

Drugs / interventions tested

Conditions studied

Sponsor

University of the Basque Country (UPV/EHU)

Who can join

Adults 18 to 55, male only, with Running or Fatigue. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Reducing fatigue and improving the recovery capabilities of runners has gained more interest over the last years. Recently, capacitive-resistive electric transfer (Tecar) therapy is commonly used by physical therapists to help athletes recover from muscle fatigue. However, empiric evidence supporting the benefits of Tecar to recovery is lacking. This study investigated the effects of a Tecar treatment performed shortly after an exhausting training session on both physiological and biomechanical parameters of running.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of a capacitive-resistive electric transfer therapy on physiological and biomechanical parameters in recreational runners: A randomized controlled crossover trial.
    Duñabeitia I, Arrieta H, Torres-Unda J, Gil J, et al · · 2018 · cited 27× · PMID 29870922 · DOI 10.1016/j.ptsp.2018.05.020

Verify or expand the search:

Other recruiting trials for Running

Currently open trials in the same condition.

Other University of the Basque Country (UPV/EHU) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03317041.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing